Author:
Fu MengRu,Du YuanZhuo,Liu Fei,Xiao Jun,Zhang Li,Zeng Yan,Yang YuJuan,Yan Yan
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Dy, G. W., Gore, J. L., Forouzanfar, M. H., Naghavi, M. & Fitzmaurice, C. Global burden of urologic cancers, 1990–2013. Eur. Urol. 71(3), 437–446 (2017).
2. Tian, Y. Q. et al. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the global burden of disease study 2019. Front. Public Health 11, 1119374 (2023).
3. Zi, H. et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Mil. Med. Res. 8(1), 60 (2021).
4. Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers 3, 17009 (2017).
5. Janzen, N. K., Kim, H. L., Figlin, R. A. & Belldegrun, A. S. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol. Clin. North Am. 30(4), 843–852 (2003).